Post Marketing Surveillance Study on Linezolid (A5951090)

Pfizer

Status: Completed

Conditions: Gram-Positive Bacterial Infections

Treatments: Drug: Linezolid

Study type: Observational

Funder types: Industry

Identifiers

NCT01564758

A5951090

GRAM POSITIVE INFECTIONS

Details and patient eligibility

About

The purpose of this study is to determine if Linezolid is safe for adult Filipino patients diagnosed with gram positive infections.

Full description

The subjects were identified after the physician decided to prescribed the drug to the subject.

Enrollment: 99 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Has clinical diagnosis of of the following, including cases with concurrent bacteremia, when suspected or known to be caused by susceptible strains of anaerobic or aerobic gram positive microorganisms - nosocomial pneumonia, community acquired pneumonia, complicated skin and skin structure infections, uncomplicated skin and skin structure infection, and vancomycin-resistant E. faecium
• Male or female, 18 years old and above

Exclusion criteria

• Known hypersensitivity
• Subjects diagnosed with pure gram-negative infection

Trial design

99 participants in 1 patient group

Group 1

Description:

Subjects that are diagnosed with gram positive infection

Treatment:

Drug: Linezolid